Regulatory and Quality Solutions (R&Q) Completes Growth Investment to Accelerate Expansion in Medical Device Regulatory Services

VCBeat (WeChat ID: vcbeat) learned from foreign media that on October 9, 2019, Regulatory and Quality Solutions (R&Q) announced the completion of a new round of growth financing. The round was jointly invested by DFW Capital Partners (DFW) and Chartwell Investments Entrepreneur & Founder Capital (Chief Capital). The investment amount was not disclosed.

R&Q is the second investment made by DFW Capital Partners VI, L.P., DFW’s new fund, which held its final closing in April 2019 with total committed capital of $500 million.

R&Q, founded in 2008 and headquartered in Pennsylvania, USA, primarily provides comprehensive regulatory and quality solutions to medical device companies. Over the past decade, R&Q has grown to nearly 200 employees with five offices. To date, the company has delivered a wide range of services for more than 1,000 projects across over 250 clients, including global regulatory affairs, quality assurance, clinical evaluations, large-scale remediation, and post-market surveillance. This round of financing will be used to accelerate R&Q’s growth trajectory.

R&Q’s core team is predominantly composed of women. Co-founder and President Maria Fagan brings nearly 30 years of experience in medical device development and regulatory compliance within the Regulatory Affairs (RA) and Quality Assurance (QA) fields. Prior to co-founding R&Q, she served as Director of European Quality Assurance and Regulatory Affairs at a renowned medical device company.

Upon the completion of this round of financing, Kurt Brykman, Operating Partner at DFW, will join the Board of Directors of R&Q. He brings extensive regulatory consulting experience, having previously held leadership positions at PAREXEL Consulting, Kinapse, and Medpace.

“From the perspectives of growth trajectory, leadership, and culture, R&Q is highly aligned with DFW and Chief Capital. We are delighted to collaborate with their teams,” said Maria Fagan, Co-Founder and President of R&Q.

DeVer Warner, head of DFW, stated, “R&Q has built an impressive team and, leveraging its robust technology, has established a leading market position in meeting the increasingly complex needs of medical device customers. We are delighted to collaborate with this team to help sustain its rapid growth.”

DFW, headquartered in New Jersey with an office in Maryland, is a private equity investment firm focused on the mid-to-low-end market, with a primary emphasis on the healthcare CRO sector.

Chief Capital is a private investment firm with over 40 years of investment experience. It primarily focuses on companies in the lower-to-mid market segments, with an emphasis on healthcare services and niche manufacturing.

(Compiled by He Li)